Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thiamax-100 is a finished pharmaceutical formulation developed and marketed by SBM Enterprises (SBM Pharma). It contains 100 mg of thiamine hydrochloride (Vitamin B1), an essential water-soluble vitamin required for glucose metabolism and the proper functioning of the nervous and cardiovascular systems. As a coenzyme for pyruvate dehydrogenase and transketolase, thiamine plays a critical role in ATP production. Thiamax-100 is used for the treatment and prevention of thiamine deficiency, including conditions such as beriberi and Wernicke-Korsakoff syndrome. SBM Pharma operates as a PCD pharma franchise, distributing this product as a branded generic in India.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Thiamax-100.